1997
DOI: 10.1161/01.cir.96.10.3579
|View full text |Cite
|
Sign up to set email alerts
|

Gap Junction Uncoupler Heptanol Prevents Cell-to-Cell Progression of Hypercontracture and Limits Necrosis During Myocardial Reperfusion

Abstract: These results demonstrate that hypercontracture may be transmitted to adjacent myocytes through gap junctions and that heptanol may interfere with this transmission and reduce the final extent of myocardial necrosis during reoxygenation or reperfusion. These findings are consistent with the hypothesis tested and open a new approach to limitation of infarct size by pharmacological control of gap junction conductance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
126
0
4

Year Published

1999
1999
2012
2012

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 181 publications
(142 citation statements)
references
References 25 publications
12
126
0
4
Order By: Relevance
“…31 All of these data support our view that in the hyperlipidemic rabbits downregulation of cardiomyocyte gap junctions may contribute to the impaired systolic function.…”
Section: Discussionsupporting
confidence: 75%
“…31 All of these data support our view that in the hyperlipidemic rabbits downregulation of cardiomyocyte gap junctions may contribute to the impaired systolic function.…”
Section: Discussionsupporting
confidence: 75%
“…Additionally, hypercontracture has been shown to be transmitted from cell to cell through GJs in paired cardiomyocytes. 6,7 These observations suggest that CBN is propagated from cell to cell through GJs, but not through hemichannels during reperfusion. CBN is distributed exclusively to the lateral borders of risk area in the mid-myocardium and does not propagate in the non-risk area beyond the border (Figure 7).…”
Section: Involvement Of Gjic In Spread Of Cbn and Infarct Developmentmentioning
confidence: 90%
“…GJs coordinate metabolic and electrical signals at long distances from the original stimulus site (Saez et al, 2003). In pathological conditions, inhibition of astrocyte GJs has been shown either to reduce (Garcia-Dorado et al, 1997;Rawanduzy et al, 1997;Cotrina et al, 1998) or to enhance (Blanc et al, 1998;Siushansian et al, 2001;Frantseva et al, 2002) damage. The mechanisms by which GJs mediate these effects could be by reducing the ability of the astrocytes to remove extracellular toxic soluble factors and/or by maintaining the propagation of proapoptotic or survival signals between dying and healthy cells.…”
Section: Introductionmentioning
confidence: 99%